Zenas BioPharma, Inc. Common Stock (ZBIO) — Long-term Investment Intensity
Zenas BioPharma, Inc. Common Stock (ZBIO) has a Long-term Investment Intensity of 4.4% as of June 2026. Long-term investments of $30.76 Million represent 4.4% of total assets of $701.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Zenas BioPharma, Inc. Common Stock's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Zenas BioPharma, Inc. Common Stock Long-term Investment Intensity (2025–2025)
This chart shows how Zenas BioPharma, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of June 2026, the intensity stands at 4.4%, reflecting long-term investments of $30.76 Million against total assets of $701.69 Million USD. For the complete balance sheet picture, see Zenas BioPharma, Inc. Common Stock total assets.
Annual Long-term Investment Intensity for Zenas BioPharma, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Zenas BioPharma, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Zenas BioPharma, Inc. Common Stock balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 4.5% | $17.27 Million | $383.64 Million | — |